# Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

> **NCT06750458** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 75 (estimated)

## Conditions studied

- Glioma
- Dapagliflozin (Forxiga)
- Dexamethasone

## Interventions

- **DRUG:** Dapagliflozin placebo
- **DRUG:** Placebo
- **DRUG:** DexamethasoneGroup III (n=25) (Dexamethasone group)

## Key facts

- **NCT ID:** NCT06750458
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-20
- **Primary completion:** 2026-10-20
- **Final completion:** 2026-12-20
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06750458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06750458, "Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06750458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*